Previous Article | Next Article 
Molecular and Cellular Biology, September 2001, p. 6312-6321, Vol. 21, No. 18
Department of Molecular Biology, The
University of Texas Southwestern Medical Center at Dallas, Dallas,
Texas 75390-9148
Received 28 March 2001/Returned for modification 8 May
2001/Accepted 21 June 2001
Activation of muscle-specific genes by the MEF2 transcription
factor is inhibited by class II histone deacetylases (HDACs) 4 and
5, which contain carboxy-terminal deacetylase domains and amino-terminal extensions required for association with MEF2. The
inhibitory action of HDACs is overcome by myogenic signals which
disrupt MEF2-HDAC interactions and stimulate nuclear export of these
transcriptional repressors. Nucleocytoplasmic trafficking of HDAC5 is
mediated by binding of the chaperone protein 14-3-3 to two
phosphoserine residues (Ser-259 and Ser-498) in its amino-terminal extension. Here we show that HDAC4 and -5 each contain a
signal-responsive nuclear export sequence (NES) at their extreme
carboxy termini. The NES is conserved in another class II HDAC, HDAC7,
but is absent in class I HDACs and the HDAC-related corepressor,
MEF2-interacting transcription repressor. Our results suggest that this
conserved NES is inactive in unphosphorylated HDAC5, which is
localized to the nucleus, and that calcium-calmodulin-dependent protein kinase (CaMK)-dependent binding of 14-3-3 to phosphoserines
259 and 498 activates the NES, with consequent export of the
transcriptional repressor to the cytoplasm. A single amino acid
substitution in this NES is sufficient to retain HDAC5 in the nucleus
in the face of CaMK signaling. These findings provide molecular insight
into the mechanism by which extracellular cues alter chromatin
structure to promote muscle differentiation and other MEF2-regulated processes.
Whether or not a gene is
transcribed is dependent on the packaging state of local chromatin,
which is organized in nucleosomes. Chromosomal DNA present in condensed
chromatin is generally inaccessible to high-molecular-weight
transcriptional machinery and is thus transcriptionally silent.
However, acetylation of lysine residues in the tails of nucleosomal
histones relaxes chromatin structure and promotes gene expression. This
posttranslational modification is catalyzed by histone acetyl
transferases (HATs). Histone acetylation also provides a reinforcing
mechanism for chromatin relaxation by creating binding sites for
bromodomain-containing transcriptional activators, which typically
possess HAT activity. The stimulatory effects of HATs on gene
transcription are antagonized by histone deacetylases (HDACs) (reviewed
in reference 30).
Skeletal muscle provides a tractable model system to study the
dynamic interplay between HATs and HDACs in the control of cellular differentiation (reviewed in reference 23).
During the formation of skeletal muscle, undifferentiated myoblasts
irreversibly exit the cell cycle and fuse to form multinucleated
myofibers with an organized contractile apparatus. Skeletal myogenesis
is controlled by a highly specific transcriptional program, which regulates subordinate genes in either a positive or a negative manner.
Members of the MEF2 family of transcription factors serve a central
role in governing this program (reviewed in reference 1).
MEF2 belongs to the MADS-box superfamily of transcription factors and
binds an A/T-rich element present in the regulatory regions of
numerous muscle-specific genes. The four MEF2 factors, MEF2A, -B, -C,
and -D, share homology in an amino-terminal MADS domain, which mediates
DNA binding and dimerization, and an adjacent MEF2 domain, which
regulates cofactor interactions. MEF2 can function as either a
transcriptional activator or repressor, depending on whether it is
physically associated with HATs or HDACs. Binding of the p300
coactivator, which possesses HAT activity, to the MADS-MEF2 domains of
MEF2 results in activation of downstream target genes
(28). Conversely, binding of class II HDAC4 and -5 to the
same region of MEF2 converts the transcription factor into a
potent repressor of gene expression (15, 16, 24, 33).
Class II HDACs contain a carboxy-terminal catalytic domain and an
amino-terminal extension that mediates binding to MEF2 (4, 6,
31). HDAC4 and -5 act as potent repressors of skeletal myogenesis by virtue of their ability to associate with MEF2
(17). However, during myogenesis they dissociate from MEF2
and are exported to the cytoplasm, thereby freeing MEF2 to stimulate
muscle gene expression (21). The effect of myogenic
signals on HDAC localization can be mimicked by
calcium-calmodulin-dependent protein kinase (CaMK) signaling
(21). Previously, we showed that CaMK-mediated nuclear
export of HDAC5 was dependent on phosphorylation of two serine residues
in its amino-terminal extension, Ser-259 and Ser-498 (21).
Phosphorylation at these residues creates docking sites for the
intracellular chaperone protein 14-3-3 (22). Nuclear export of HDAC5 appears to require 14-3-3 binding, since replacement of
Ser-259 and Ser-498 with alanine abolishes not only its association with 14-3-3 but also its nuclear export (21, 22). However, the existence of carboxy-terminal truncation mutants of HDAC5 that
retain the ability to bind 14-3-3 but remain in the nucleus despite
active CaMK signaling suggests that 14-3-3 binding alone is
insufficient to drive HDAC5 out of the nucleus (22).
To further define the mechanism that regulates nuclear export of class
II HDACs, we analyzed the behavior of a series of HDAC5 mutants. Here
we describe a CaMK-responsive nuclear export sequence (NES) present
near the extreme carboxy terminus of HDAC5. This regulatory sequence is
conserved in HDAC4 and -7 but is absent in class I HDACs and the
MEF2-interacting transcription repressor (MITR). Our studies indicate
that phosphorylation-dependent binding of 14-3-3 to the amino-terminal
extension of HDAC4 and -5 is required to activate the carboxy-terminal
NES, culminating in shuttling of these transcriptional repressors to
the cytoplasm. These results provide a molecular explanation for the
signal-responsiveness of class II HDACs and the MEF2 target genes that
are under their control.
Cell culture and transfections.
COS cells were cultured in
Dulbecco's modified Eagle's medium containing 10% fetal bovine
serum, 2 mM L-glutamine, and penicillin-streptomycin. Cells
were plated at a density of 5 × 105 to
10 × 105 cells/35-mm-diameter dish 1 day prior to transfection with the lipid-based reagent Fugene 6 (Roche
Molecular Biochemicals).
Plasmids.
Epitope-tagged derivatives of 14-3-3 Coimmunoprecipitation and immunoblotting.
COS cells
were harvested 2 days posttransfection in phosphate-buffered
saline containing 0.5% Triton X-100, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), and protease inhibitors (Complete; Roche Molecular Biochemicals). After brief sonication and
removal of cellular debris by centrifugation, FLAG-tagged proteins were
immunoprecipitated from cell lysates using anti-FLAG affinity resin
(Sigma) and were washed 5 times with lysis buffer. Precipitated
proteins were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, transferred to polyvinylidene difluoride membranes,
and immunoblotted as indicated with either anti-Myc antibody
(polyclonal, A-14; Santa Cruz), pan anti-14-3-3 antibody (polyclonal,
A-19; Santa Cruz), or a monoclonal anti-FLAG antibody (M2; Sigma).
Proteins were visualized with a chemiluminescence system (Santa Cruz).
Indirect immunofluorescence.
COS cells were grown on glass
coverslips, fixed in 10% formalin and stained in phosphate-buffered
saline containing 3% bovine serum albumin and 0.1% Nonidet-P40.
Primary antibodies against FLAG (M2; Sigma), Myc (polyclonal, A-14;
Santa Cruz), or HA (polyclonal, Y-11; Santa Cruz) were used at a
dilution of 1:200. Secondary antibodies conjugated to either
fluorescein or Texas Red (Vector Labs) were also used at a dilution of
1:200. All images were captured at a magnification of ×40.
Generation of HDAC5 mutants lacking internal amino
acids.
In response to CaMK signaling, HDAC5 is
efficiently exported from the nucleus to the cytoplasm
(21). This process is dependent on phosphorylation of
HDAC5 at two serine residues, Ser-259 and Ser-498, in its
amino-terminal extension (21). These sites are conserved
in HDAC4, which also displays CaMK responsiveness. However, HDAC4 tends
to be less restricted to the nucleus than HDAC5 in the absence of CaMK
signaling due to constitutive association of this repressor with the
chaperone protein 14-3-3 (7, 22, 34). Nuclear-cytoplasmic
trafficking of HDAC5 also requires carboxy-terminal
sequences (22). Previously, we demonstrated that
sequences between amino acids 767 and 921 in the catalytic domain of
HDAC5 were capable of functioning as an autonomous NES when tethered to
a heterologous protein (21). To further define the NES in
HDAC5, we generated a series of HDAC5 deletion mutants lacking
increasing amounts of carboxy-terminal sequence in the context of the
full-length protein. Schematic depictions of these proteins are shown
in Fig. 1A. Each mutant protein was
expressed at the appropriate size and was efficiently associated with
MEF2, as determined by sequential immunoprecipitation and
immunoblotting (Fig. 1B).
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.18.6312-6321.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of a Signal-Responsive Nuclear
Export Sequence in Class II Histone Deacetylases
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, HDAC4,
and HDAC5 containing amino-terminal FLAG or Myc tags, MEF2C with a
carboxy-terminal Myc tag, and CaMKI with a 3× hemagglutinin (HA)
tag were generated using the pcDNA3.1 expression vector (Invitrogen).
The cDNA encoding activated CaMKI contains a stop codon in place of
isoleucine-294, thereby removing the carboxy-terminal autoinhibitory
domain (8). This CaMK mutant functions constitutively
without the requirement for calcium and calmodulin for activation.
Mutagenesis was performed with the Quikchange kit (Stratagene).
Internal deletion mutants of HDAC5 were generated by PCR with PFU Turbo
polymerase (Stratagene).
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
View larger version (30K):
[in a new window]
FIG. 1.
Internal deletion mutants of HDAC5. (A) Schematic
representations of HDAC5 deletion mutants containing amino acids 1 to
767 but lacking sequences in the HDAC domain from position 768 to 1080. The locations of the NLS, MEF2-binding domain, and CaMK phosphorylation
sites (Ser-259 and Ser-498) are indicated. The right-hand panel
summarizes localization data shown in Fig. 2. N, nuclear; C,
cytoplasmic; N/C, nuclear and cytoplasmic; P, phosphorylation sites.
(B) COS cells were cotransfected with expression plasmids encoding
FLAG-tagged versions of the indicated HDAC5 protein and a vector for
Myc-tagged MEF2C (1 µg each). HDAC5 was immunoprecipitated from cell
lysates using a monoclonal anti-FLAG antibody, and associated MEF2 was
detected by immunoblotting with polyclonal anti-Myc antibodies (bottom
panel). The membrane was reprobed with anti-FLAG antibody to reveal
HDAC5 protein (upper panel).
Subcellular distribution of HDAC5 deletion mutants.
Indirect
immunofluorescence experiments were performed to determine the relative
contribution of specific carboxy-terminal sequences in HDAC5 in
governing its subcellular distribution. For these experiments, COS
cells were transfected with FLAG epitope-tagged derivatives of the
indicated HDAC5 mutants in the absence or presence of a plasmid for
constitutively active CaMKI. Consistent with our previous finding
(21), HDAC5 was localized exclusively to the nucleus of
these cells and was efficiently transported to the cytoplasm in
response to CaMK signaling (Fig. 2A and
B). Surprisingly, deletion of HDAC5 sequences between amino acids 768 and 921 altered the localization of HDAC5 from the nucleus to a
whole-cell pattern (Fig. 2C and E). Possible explanations for the
presence of these mutants in the cytoplasm in the absence of CaMK
signaling are that the deletions unmask an otherwise cryptic NES,
remove sequences involved in nuclear retention, or hinder the
function of the nuclear localization signal (NLS) between amino
acids 260 and 304 (21). Despite this uncertainty, the
deletion mutants clearly retained the capacity to undergo
CaMK-dependent nuclear export (Fig. 2D and F).
|
Fusion of HDAC5 amino acids 1081 to 1122 to GFP.
NESs are
often defined by their ability to confer nuclear export to heterologous
proteins (reviewed in reference 5). To further define the
properties of the putative NES in HDAC5, we fused it to green
fluorescent protein (GFP) and assessed the localization of the
resultant fusion protein. GFP alone was found in both the nucleus and
the cytoplasm of transfected COS cells, with more prominent
localization in the nucleus (Fig. 3A, a
and b). Surprisingly, fusion of HDAC5 amino acids 1081 to 1122 to the
carboxy terminus of GFP failed to alter the localization of the protein
in either the absence or the presence of activated CaMK (Fig. 3A, c and d). Identical results were obtained when this HDAC5 sequence was fused
to the amino terminus of GFP (data not shown). These findings raised
the possibility that the HDAC5 NES might function in a protein
context-dependent manner, possibly requiring additional sequences for
full activity.
|
Fusion of HDAC5 amino acids 1081 to 1122 to MITR. MITR (29), also referred to as HDRP (HDAC-related protein) (38), shares high homology with the amino-terminal extensions of HDAC4 and -5 and interacts with MEF2 but lacks an HDAC catalytic domain (29, 38). Nevertheless, MITR inhibits MEF2-dependent reporter genes by recruiting other HDACs and the CtBP corepressor (29, 36, 38). CaMK signaling stimulates binding of 14-3-3 to MITR, and this binding is dependent on phosphorylation of two serines in the protein, Ser-218 and Ser-448, that are analogous to Ser-259 and Ser-498 of HDAC5 (37). However, unlike HDAC4 and -5, MITR remains in the nucleus of CaMK-expressing cells, presumably due to the lack of a carboxy-terminal NES. Experiments were next performed to determine whether amino acids 1081 to 1122 of HDAC5 could function as a constitutive or signal-dependent NES when fused to MITR.
MITR was localized in discrete nuclear bodies in transfected COS cells (Fig. 3B, a). A similar expression pattern was observed in other cell types, including C2 myoblasts and 10T1/2 fibroblasts (data not shown). In response to CaMK signaling, MITR remained in the nucleus, although the protein was evenly distributed and no longer localized to nuclear speckles (Fig. 3B, b). This redistribution of MITR is dependent on CaMK-dependent binding of 14-3-3 to Ser-218 and Ser-448 (37). MITR remained nuclear when amino acids 1081 to 1122 of HDAC5 were fused to its carboxy terminus, although the protein was typically found in fewer foci than wild-type MITR (Fig. 3B, c). However, in response to CaMK, the MITR-HDAC5 fusion protein was efficiently transported from the nucleus to the cytoplasm. Translocation of the MITR fusion protein was a result of active nuclear export, since the process was blocked by leptomycin B, a fungal toxin that inhibits the exportin protein CRM1 (data not shown). These findings suggest that amino acids 1081 to 1122 of HDAC5 function as a signal-dependent NES.Fine mapping the HDAC5 NES.
HDAC5 nuclear export is dependent
on the CRM1 exportin protein (21). A consensus
CRM1-dependent NES has been established (Leu-X-X-X-Leu-X-X-Leu-X-Leu)
(2). However, in several known CRM1 substrates, isoleucine
and/or valine substitute for leucine at one or more positions
(5). We analyzed HDAC5 amino acids 1081 to 1122 for the
presence of a consensus NES and found none (Fig.
4A). However, this region of human and
mouse HDAC5 contains two leucines and two valines that are conserved in
HDAC4 and -7. In this regard, HDAC4 also undergoes CaMK-mediated
nuclear export (22) and HDAC7 is likely to be subject
to similar control on the basis of its homology to HDAC4 and -5 (12).
|
768-1080
protein (Fig. 1A) to circumvent potential complications in
interpretation of the data due to the presence of redundant NESs in the
carboxy terminus of HDAC5 (see below). The HDAC5768-1080 protein was
efficiently transported from the nucleus to the cytoplasm in
response to CaMK signaling (Fig. 4B, a and b). In contrast, when
Val-1086 was converted to alanine (mutant 768-1080 V1086A),
CaMK-mediated nuclear export was significantly impaired, although it
was not eliminated (Fig. 4B, c and d). Simultaneous conversion of
Leu-1091 and Leu-1092 to alanine (mutant 768-1080 L1091/1092A)
completely abolished nuclear export of the protein (Fig. 4B, e and f).
A consensus CaMK phosphorylation site (Arg-X-X-Ser) is present within
HDAC5 amino acids 1081 to 1122 (Fig. 4A). To address its possible
involvement in CaMK-mediated nuclear export of HDAC5, we generated a
mutant protein containing alanine in place of the potential
phosphoacceptor at position 1108. However, as shown in Fig. 4B (g and
h), this substitution had no effect on export of the HDAC5768-1080 protein.
Identical results to those presented in Fig. 4B were obtained when
Val-1086, Leu-1091, Leu-1092, or Ser-1108 was converted to alanine in
the context of the MITR-HDAC5 fusion protein described in Fig. 3B (data
not shown). Taken together, these results suggest that Val-1086,
Leu-1091, and Leu-1092 are critical elements of the HDAC5 NES and that
the CaMK signal for nuclear export is transmitted to these sequences
via cross-talk with amino-terminal residues in HDAC5 rather than by
phosphorylation of an adjacent site (e.g., Ser-1108).
A single NES regulates nuclear export of HDAC5.
Our previous
demonstration that amino acids 768 to 921 can function as an NES when
fused to GFP and that a deletion mutant of HDAC5 lacking 101 carboxy-terminal amino acids undergoes CaMK-dependent nuclear
export raised the possibility that HDAC5 contains redundant NESs
(21). Indeed, there is precedent for multiple NESs in
other transcriptional regulators (39). To further address
this issue, we generated an HDAC5 deletion mutant lacking only amino
acids 1081 to 1122 (mutant 1-1080). In addition, changes of Val-1086 to
alanine and Leu-1092 to alanine were generated in the context of
full-length HDAC5 (mutants V1086A and L1092A, respectively). As shown in Fig.
5A (a and b),
full-length HDAC5 was efficiently exported to the cytoplasm in response
to CaMK signaling. In contrast, the 1-1080 and V1086A mutants of
HDAC5 were largely resistant to CaMK-mediated nuclear export (Fig. 5A,
c through f), and replacement of Leu-1092 with alanine resulted in a
complete block to HDAC5 nuclear export (Fig. 5A, g and h). The relative
importance of Val-1094 in governing nuclear export of HDAC5 was not
addressed. However, given its proximity to Leu-1092, it is also likely
to play an important role in the HDAC5 NES. Of note, this
experiment was performed with a mutant in which only Leu-1092 was
converted to alanine, while other experiments in this study employed
the double Leu-1091 and Leu-1092 to alanine mutant. The double-alanine mutant was originally constructed to avoid complications
due to possible redundant use of the adjacent leucines in the
NES. However, the results presented here demonstrate that the conserved
leucine at position 1092 is a critical regulator of HDAC5 nuclear
export.
|
Block to HDAC5 nuclear export despite efficient binding to 14-3-3. The above results strongly suggest that HDAC5 contains a single NES near its extreme carboxy terminus and that Val-1086 and Leu-1092 serve critical functions within this NES. However, one explanation for the inability of these mutants to undergo nuclear export is that the amino acid substitutions inhibit binding of 14-3-3 to HDAC5, which is required for nuclear-cytoplasmic trafficking of this repressor (22). Indirect immunofluorescence and coimmunoprecipitation experiments were performed to address this possibility. As shown in Fig. 5B (a and b), in cells coexpressing HDAC5 and 14-3-3, HDAC5 was exclusively nuclear, while 14-3-3 was found in both the nucleus and the cytoplasm. This localization pattern is identical to that seen when either protein is expressed individually, suggesting that the proteins fail to interact in the absence of a signal (22). In contrast, in the presence of activated CaMK both HDAC5 and 14-3-3 were colocalized exclusively in the cytoplasm, consistent with our prior findings showing that CaMK signaling promotes association of the two proteins (Fig. 5B, c and d) (22). Likewise, in response to CaMK signaling, 14-3-3 efficiently associated with the L1091A-L1092A mutant of HDAC5, as indicated by the colocalization of these two proteins in the nuclear compartment (Fig. 5B, g and h). These results were further supported by coimmunoprecipitation experiments, which revealed CaMK-inducible binding of endogenous 14-3-3 to both wild-type HDAC5 and the L1091-L1092A mutant (Fig. 5C). Together, these results suggest that the failure of the L1091-L1092A mutant to undergo nuclear export is due to a loss of NES function rather than a block to 14-3-3 binding to the amino terminus of HDAC5.
A conserved NES in HDAC4.
HDAC4 and -5 share 54% amino acid
identity. Consistent with this sequence homology, both proteins are
potent inhibitors of MEF2-dependent transcription and skeletal
myogenesis (15, 16, 17, 24, 33). Furthermore, like HDAC5,
HDAC4 is efficiently exported from the nucleus to the cytoplasm in
response to CaMK signaling, and this process is dependent on 14-3-3 binding (22). However, there is evidence to suggest that
HDAC4 and -5 are differentially regulated in vivo. For example, ectopic
expression of HDAC4 in various cell types has revealed that the protein
is constitutively localized to the cytoplasm in 50 to 80% of the cells
in which it is expressed, while HDAC5 is exclusively nuclear in the
same cells under the same conditions (Fig. 5 and
6) (22,
24).
|
NES mutants of HDAC4 retain the capacity to bind 14-3-3.
While HDAC5 binding to 14-3-3 is largely dependent on
CaMK-mediated phosphorylation, HDAC4 binds constitutively to
14-3-3 in yeast and mammalian cells, presumably due to the basal
activity of an as-yet unidentified kinase (7, 22, 34).
Binding of 14-3-3 to HDAC4 is dependent on phosphorylation at three
serine residues: Ser-246, Ser-467, and Ser-632 (7, 22,
34). Ser-246 and Ser-467 in HDAC4 are analogous to Ser-259 and
Ser-498, respectively, in HDAC5. We performed experiments to determine
whether sequences in the NES of HDAC4 influenced association with
14-3-3. Consistent with our prior findings, HDAC4 was predominantly
cytoplasmic in COS cells coexpressing 14-3-3 (Fig. 6B, a)
(22). Ectopic 14-3-3, which localizes to both the nucleus
and the cytoplasm in the absence of HDAC4 (22), was
exclusively cytoplasmic in the presence of HDAC4 in either the
absence or the presence of activated CaMK (Fig. 6B, b and d). The
NES mutant of HDAC4 (L1062A) retained the capacity to bind
14-3-3, as evidenced by the nuclear accumulation of both proteins in
the absence of CaMK signaling (Fig. 6B, e and f). The HDAC4 mutant and
14-3-3 also colocalized in the presence of activated CaMK (Fig. 6B, g
and h). Of note, increased cytoplasmic staining of the HDAC4 L1062A
mutant was evident in cells overexpressing 14-3-3 (compare Fig. 6A, f,
and B, g). This enhanced cytoplasmic localization could be due to
the ability of 14-3-3 to block binding of the nuclear import factor,
importin 
, to HDAC4 (7) (see Discussion).
Nevertheless, these data clearly demonstrate that nuclear
export-resistant mutants of HDAC4 retain the capacity to constitutively
associate with 14-3-3 and suggest that the failure of these mutants to
localize in the cytoplasm is due to an NES-autonomous defect.
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
The results of this study demonstrate that class II HDACs contain conserved NESs located at their extreme carboxy termini. These NESs function in a signal-dependent manner requiring phosphorylation and subsequent binding of 14-3-3 to serine residues near the amino termini. These results provide a potential molecular explanation for the dynamic nucleocytoplasmic shuttling of HDACs during skeletal myogenesis and in response to CaMK signaling (21).
CRM1-dependent nuclear export. A major pathway for nuclear export involves the exportin protein CRM1 (5). CRM1 has been implicated in the regulation of several transcription factors, including NFAT and STAT1 (20, 39). A role for CRM1 in nuclear export of HDACs is strongly supported by the ability of the CRM1 antagonist, leptomycin B, to block constitutive nuclear export of HDAC4 and CaMK-mediated nuclear export of HDAC5 (21, 24).
A consensus leucine-rich binding site for CRM1 has been defined (Leu-X-X-X-Leu-X-X-Leu-X-Leu) (2), although CRM1-dependent NESs that diverge from this consensus on the basis of amino acid composition and spacing have also been identified, with isoleucine and valine being commonly substituted for leucine among these divergent NESs. Sequence analysis of class II HDACs failed to reveal a consensus NES. However, by examining the subcellular localization of a panel of deletion and point mutants, we have defined an NES (Val-X-X-X-X-X-Leu-X-Val) present in HDAC4, -5, and -7 but absent in class I HDACs and MITR. To our knowledge, this regulatory motif has not been previously described, and thus it represents a novel CRM1-dependent NES. HDAC6 is unique among the class II HDACs in that it contains two tandem deacetylase domains and lacks a MEF2-binding domain (6). Furthermore, HDAC6 appears to translocate to the nucleus in the absence of mitogens (32). Consistent with these differences in regulation and function relative to other class II HDACs, HDAC6 lacks the carboxy-terminal NES described here but contains an amino-terminal NES not found in HDAC4, -5, and -7 (32). NESs are commonly defined by their ability to confer cytoplasmic localization to heterologous proteins. However, the localization of chimeric proteins containing the HDAC5 NES fused to either GFP or the MITR corepressor was unaltered relative to the wild-type proteins (Fig. 3A and B). In contrast, an MITR-HDAC5 fusion protein was efficiently translocated to the cytoplasm in response to CaMK signaling, whereas wild-type MITR remained nuclear (Fig. 3). This signal-dependent nuclear export was specific for the MITR fusion protein, as the localization of the GFP chimera was unaltered by activated CaMK. Thus, while the HDAC5 NES fails to act as a constitutive export signal, it is capable of functioning in a signal-dependent manner when tethered to CaMK response elements present in the amino-terminal extensions of HDAC4, -5, and -7.Role of other carboxy-terminal residues in the regulation of HDAC5 localization. We previously analyzed the localization of a panel of carboxy-terminal deletion mutants of HDAC5 (21). Removal of approximately 100 carboxy-terminal amino acids from HDAC5 led to a diffuse, whole-cell pattern of HDAC5 localization, and a mutant lacking an additional 100 amino acids was completely excluded from the nucleus. Further deletion of HDAC5 carboxy-terminal sequences up to residue 767 resulted in a nuclear pattern of HDAC5 localization. We concluded from these results that sequences of HDAC5 between 768 and 921 function to localize the protein in the cytoplasm (21). Indeed, a GFP fusion protein containing these sequences was efficiently targeted to the cytoplasm. However, as shown here, deletion of amino acids 768 to 921 in the context of full-length HDAC5 had no effect on CaMK-mediated nuclear export of this protein (Fig. 2E and F). Furthermore, single amino acid substitutions in the carboxy-terminal NES of HDAC5 are sufficient to block nuclear export (Fig. 5A, e and f). Therefore, the bona fide NES in HDAC5 is located near the extreme carboxy terminus of the protein. The basis for the altered localization of the carboxy-terminal truncation mutants of HDAC5 remains unclear, but several possible explanations exist. The amino acid deletions may (i) expose a cryptic NES in HDAC5 that is normally masked, (ii) block the function of the NLS in HDAC5 located between amino acids 260 and 304, (iii) expose sequences in HDAC5 that serve to dock the protein in the cytoplasm, or (iv) remove sequences in HDAC5 involved in nuclear retention. Resolution of these issues awaits further experimentation.
Cross-talk between the amino and carboxy termini of class II
HDACs?
How do signals received within the amino-terminal
extensions of class II HDACs communicate with the carboxy-terminal NES? CaMK-mediated nuclear export of HDAC5 appears to require binding of
14-3-3 to Ser-259 and Ser-498 in its amino terminus. Indeed, substitution of these serines with alanines blocks both 14-3-3 binding
and nuclear export of HDAC5 (22). However, association with 14-3-3 alone is not sufficient to localize HDAC5 in the cytoplasm, since NES mutants of HDAC5 associate with 14-3-3 in a CaMK-dependent manner but remain in the nucleus (Fig. 5 and 6). The simplest interpretation of these findings is schematized in Fig.
7. According to this model,
amino-terminal sequences in HDAC5 mask the carboxy-terminal NES to
retain HDAC5 in the nucleus. Upon 14-3-3 binding to phosphorylated Ser-259 and Ser-498, the conformation of HDAC5 is altered such that the
carboxy-terminal NES becomes exposed, allowing export of the repressor
to the cytoplasm. Based on the sensitivity of HDAC5 nuclear export to
leptomycin B, this process likely involves binding of CRM1 to the NES,
although we have not demonstrated this interaction directly.
|
, to this
transcriptional repressor (7). Consistent with this, we previously mapped the NLS in HDAC5 to sequences that are flanked by
Ser-259 and Ser-498 (21). Thus, 14-3-3 may serve a dual
role in the regulation of HDAC localization by functioning to expose the NES and mask the NLS.
The model in Fig. 7 predicts that nuclear entry of HDAC5 requires
dephosphorylation of Ser-259 and Ser-498 by a phosphatase. Indeed,
treatment of cells with the phosphatase inhibitor calyculin A has
been shown to increase association of 14-3-3 with HDAC4 (7). Calyculin A is a broad-specificity phosphatase
inhibitor that blocks the activities of protein phosphatase 1 and
protein phosphatase 2A. Thus, the exact identity of the HDAC
phosphatase remains unknown. This phosphatase is of particular
interest, because it would be expected to antagonize CaMK signaling to
MEF2-dependent genes by enhancing the repressive activity of class II HDACs.
Class II HDAC-SMRT-N-CoR interactions. Class II HDACs were recently shown to associate with nuclear receptor corepressor (N-CoR) and silencing mediator for retinoid and thyroid receptors (SMRT) (10, 12). Interestingly, the binding site for SMRT-N-CoR on class II HDACs overlaps with the NES we describe here, suggesting that these corepressors may regulate the function of the HDAC NES. Indeed, a recent report demonstrated that SMRT is capable of driving HDAC4 from the cytoplasm to the nucleus (35). It will be interesting to determine whether or not SMRT-N-CoR masks the carboxy-terminal NESs in HDAC4 and -5 and, if so, whether CaMK signaling alters this inhibitory activity.
MITR: a constitutively nuclear repressor of MEF2-dependent transcription. MITR is highly homologous to the amino-terminal extensions of class II HDACs but lacks a carboxy-terminal catalytic domain (29, 38). Like HDAC4 and -5, MITR is a repressor of skeletal myogenesis and contains two regulatory serine residues that are targets for CaMK signaling (37). Phosphorylation of these sites releases MITR from MEF2 through a 14-3-3-dependent mechanism. However, unlike HDAC4 and -5, MITR remains in the nucleus following phosphorylation by CaMK, although the subnuclear distribution of the protein is altered (Fig. 3B, b). These results demonstrate that MITR is a nuclear export-resistant inhibitor of MEF2 and suggest that MITR may perform functions in the nucleus that distinguish it from HDAC4 and -5. Of note, analysis of the human genome sequence reveals the presence of a coding region for a putative HDAC domain approximately 50 kb downstream of the MITR sequence on chromosome 7, and this putative MITR HDAC domain possesses the conserved leucines and valines present in the class II HDAC-specific NES. The sequence of this putative NES is as follows: Val-Ser-Ala-Leu-Ala-Ser-Leu-Thr-Val.
Nuclear export of HDACs in the control of muscle differentiation. Previously, we performed chromatin immunoprecipitation assays to examine the acetylation state of nucleosomal histones surrounding MEF2 binding sites in the regulatory regions of muscle-specific genes (17). Our results demonstrated that the degree of histone acetylation associated with these MEF2 response elements was significantly higher in differentiated myotubes than in undifferentiated myoblasts, supporting the notion that repression of the skeletal muscle differentiation program is coupled to histone deacetylation. Consistent with this, we have shown that HDAC5, which is a potent inhibitor of MEF2-dependent transcription, resides in the nucleus of proliferating, undifferentiated myoblasts and shuttles to the cytoplasm when cells are triggered to differentiate (21). Recently, HDAC7 was also shown to undergo nuclear export in response to myogenic cues (3). The data presented here provide a molecular explanation for these findings (see Fig. 7).
Our studies demonstrate that CaMK acts as a potent export kinase for class II HDACs. However, the existence of other HDAC kinases remains likely. Furthermore, it is conceivable that different class II HDACs are regulated by distinct kinases. Indeed, we have previously shown that HDAC4 and -5 are subject to differential regulation in yeast and mammalian cells (22).The MEF2-HDAC axis in the control of diverse biological processes. Class II HDACs are expressed at highest levels in skeletal muscle, heart, and brain (4, 6, 31), the same tissues in which MEF2 is most abundant (1). These overlapping expression patterns suggest roles for MEF2-HDAC interactions that extend beyond regulation of skeletal muscle differentiation. In neurons, MEF2 has been implicated in calcium-dependent survival pathways (18, 25), and CaMK signaling has been shown to affect learning and memory (9, 19, 27). In cardiac myocytes, the activities of MEF2 and CaMK are upregulated in response to stimuli that trigger cardiac hypertrophy and heart failure (11, 13, 14, 26, 40). As such, it is intriguing to speculate that MEF2-HDAC complexes serve to integrate normal and pathological signals in diverse organ systems.
| |
ACKNOWLEDGMENTS |
|---|
We thank S. Schreiber and A. Means for expression constructs. We are grateful to J. Page and W. Simpson for editorial assistance, A. Tizenor for graphics, and S. Bezprozvannaya for technical support.
This work was supported by grants from the National Institutes of Health, The D. W. Reynolds Center for Clinical Cardiovascular Research, and The Robert A. Welch Foundation to E.N.O. T.A.M. is a Pfizer fellow of the Life Sciences Research Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Blvd., Dallas, TX 75390-9148. Phone: (214) 648-1187. Fax: (214) 648-1196. E-mail: eolson{at}hamon.swmed.edu.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. | Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell. Dev. Biol. 14:167-196[CrossRef][Medline]. |
| 2. | Bogerd, H. P., R. A. Fridell, R. E. Benson, J. Hua, and B. R. Cullen. 1996. Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol. Cell. Biol. 16:4207-4214[Abstract]. |
| 3. |
Dressel, U.,
P. J. Bailey,
S. C. Wang,
M. Downes,
R. M. Evans, and G. E. Muscat.
2001.
A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.
J. Biol. Chem.
276:17007-17013 |
| 4. |
Fischle, W.,
S. Emiliani,
M. J. Hendzel,
T. Nagase,
N. Nomura,
W. Voelter, and E. Verdin.
1999.
A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p.
J. Biol. Chem.
274:11713-11720 |
| 5. | Gorlich, D., and U. Kutay. 1999. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell. Dev. Biol. 15:607-660[CrossRef][Medline]. |
| 6. |
Grozinger, C. M.,
C. A. Hassig, and S. L. Schreiber.
1999.
Three proteins define a class of human histone deacetylases related to yeast Hda1p.
Proc. Natl. Acad. Sci. USA
96:4868-4873 |
| 7. |
Grozinger, C. M., and S. L. Schreiber.
2000.
Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.
Proc. Natl. Acad. Sci. USA
97:7835-7840 |
| 8. | Haribabu, B., S. S. Hook, M. A. Selbert, E. G. Goldstein, E. D. Tomhave, A. M. Edelman, R. Snyderman, and A. R. Means. 1995. Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin-dependent protein kinase I kinase. EMBO J. 14:3679-3686[Medline]. |
| 9. |
Ho, N.,
J. A. Liauw,
F. Blaeser,
F. Wei,
S. Hanissian,
L. M. Muglia,
D. F. Wozniak,
A. Nardi,
K. L. Arvin,
D. M. Holtzman,
D. J. Linden,
M. Zhuo,
L. J. Muglia, and T. A. Chatila.
2000.
Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice.
J. Neurosci.
20:6459-6472 |
| 10. |
Huang, E. Y.,
J. Zhang,
E. A. Miska,
M. G. Guenther,
T. Kouzarides, and M. A. Lazar.
2000.
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway.
Genes Dev.
14:45-54 |
| 11. |
Irons, C. E.,
C. A. Sei,
H. Hidaka, and C. C. Glembotski.
1992.
Protein kinase C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes.
J. Biol. Chem.
267:5211-5216 |
| 12. |
Kao, H. Y.,
M. Downes,
P. Ordentlich, and R. M. Evans.
2000.
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.
Genes Dev.
14:55-66 |
| 13. |
Kirchhefer, U.,
W. Schmitz,
H. Scholz, and J. Neumann.
1999.
Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts.
Cardiovasc. Res.
42:254-261 |
| 14. | Kolodziejczyk, S. M., L. Wang, K. Balazsi, Y. DeRepentigny, R. Kothary, and L. A. Megeney. 1999. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr. Biol. 9:1203-1206[CrossRef][Medline]. |
| 15. |
Lemercier, C.,
A. Verdel,
B. Galloo,
S. Curtet,
M. P. Brocard, and S. Khochbin.
2000.
mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity.
J. Biol. Chem.
275:15594-15599 |
| 16. |
Lu, J.,
T. A. McKinsey,
R. L. Nicol, and E. N. Olson.
2000.
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
Proc. Natl. Acad. Sci. USA
97:4070-4075 |
| 17. | Lu, J., T. A. McKinsey, C. L. Zhang, and E. N. Olson. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233-244[CrossRef][Medline]. |
| 18. |
Mao, Z.,
A. Bonni,
F. Xia,
M. Nadal-Vicens, and M. E. Greenberg.
1999.
Neuronal activity-dependent cell survival mediated by transcription factor MEF2.
Science
286:785-790 |
| 19. |
Mayford, M.,
M. E. Bach,
Y. Y. Huang,
L. Wang,
R. D. Hawkins, and E. R. Kandel.
1996.
Control of memory formation through regulated expression of a CaMKII transgene.
Science
274:1678-1683 |
| 20. | McBride, K. M., C. McDonald, and N. C. Reich. 2000. Nuclear export signal located within theDNA-binding domain of the STAT1 transcription factor. EMBO J. 19:6196-6206[CrossRef][Medline]. |
| 21. | McKinsey, T. A., C. L. Zhang, J. Lu, and E. N. Olson. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-111[CrossRef][Medline]. |
| 22. |
McKinsey, T. A.,
C. L. Zhang, and E. N. Olson.
2000.
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.
Proc. Natl. Acad. Sci. USA
97:14400-14405 |
| 23. | McKinsey, T. A., C. L. Zhang, and E. N. Olson. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev., in press. |
| 24. | Miska, E. A., C. Karlsson, E. Langley, S. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-5107[CrossRef][Medline]. |
| 25. |
Okamoto, S.,
D. Krainc,
K. Sherman, and S. A. Lipton.
2000.
Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation.
Proc. Natl. Acad. Sci. USA
97:7561-7566 |
| 26. | Passier, R., H. Zeng, N. Frey, F. J. Naya, R. L. Nicol, T. A. McKinsey, P. Overbeek, J. A. Richardson, S. R. Grant, and E. N. Olson. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Investig. 105:1395-1406[Medline]. |
| 27. | Rongo, C., and J. M. Kaplan. 1999. CaMKII regulates the density of central glutamatergic synapses in vivo. Nature 402:195-199[CrossRef][Medline]. |
| 28. | Sartorelli, V., J. Huang, Y. Hamamori, and L. Kedes. 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010-1026[Abstract]. |
| 29. | Sparrow, D. B., E. A. Miska, E. Langley, S. Reynaud-Deonauth, S. Kotecha, N. Towers, G. Spohr, T. Kouzarides, and T. J. Mohun. 1999. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18:5085-5098[CrossRef][Medline]. |
| 30. | Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41-45[CrossRef][Medline]. |
| 31. |
Verdel, A., and S. Khochbin.
1999.
Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers.
J. Biol. Chem.
274:2440-2445 |
| 32. | Verdel, A., S. Curtet, M. P. Brocard, S. Rousseaux, C. Lemercier, M. Yoshida, and S. Khochbin. 2000. Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm. Curr. Biol. 10:747-749[CrossRef][Medline]. |
| 33. |
Wang, A. H.,
N. R. Bertos,
M. Vezmar,
N. Pelletier,
M. Crosato,
H. H. Heng,
J. Th'ng,
J. Han, and X. J. Yang.
1999.
HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.
Mol. Cell. Biol.
19:7816-7827 |
| 34. |
Wang, A. H.,
M. J. Kruhlak,
J. Wu,
N. R. Bertos,
M. Vezmar,
B. I. Posner,
D. P. Bazett-Jones, and X. J. Yang.
2000.
Regulation of histone deacetylase 4 by binding of 14-3-3 proteins.
Mol. Cell. Biol.
20:6904-6912 |
| 35. |
Wu, X. Y.,
H. Li,
E. J. Park, and J. D. Chen.
2001.
SMRTe inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains.
J. Biol. Chem.
276:24177-24185 |
| 36. |
Zhang, C. L.,
T. A. McKinsey,
J. R. Lu, and E. N. Olson.
2001.
Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.
J. Biol. Chem.
276:35-39 |
| 37. |
Zhang, C. L.,
T. A. McKinsey, and E. N. Olson.
2001.
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis.
Proc. Natl. Acad. Sci. USA
98:7354-7359 |
| 38. |
Zhou, X.,
V. M. Richon,
R. A. Rifkind, and P. A. Marks.
2000.
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5.
Proc. Natl. Acad. Sci. USA
97:1056-1061 |
| 39. | Zhu, J., and F. McKeon. 1999. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature 398:256-260[CrossRef][Medline]. |
| 40. |
Zhu, W.,
Y. Zou,
I. Shiojima,
S. Kudoh,
R. Aikawa,
D. Hayashi,
M. Mizukami,
H. Toko,
F. Shibasaki,
Y. Yazaki,
R. Nagai, and I. Komuro.
2000.
Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy.
J. Biol. Chem.
275:15239-15245 |
Molecular and Cellular Biology, September 2001, p. 6312-6321, Vol. 21, No. 18
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.18.6312-6321.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kozhemyakina, E., Cohen, T., Yao, T.-P., Lassar, A. B.
(2009). Parathyroid Hormone-Related Peptide Represses Chondrocyte Hypertrophy through a Protein Phosphatase 2A/Histone Deacetylase 4/MEF2 Pathway. Mol. Cell. Biol.
29: 5751-5762
[Abstract] [Full Text] -
Chandrasekaran, S., Peterson, R. E., Mani, S. K., Addy, B., Buchholz, A. L., Xu, L., Thiyagarajan, T., Kasiganesan, H., Kern, C. B., Menick, D. R.
(2009). Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes. FASEB J.
23: 3851-3864
[Abstract] [Full Text] -
Sun, S., Wong, E. W P, Li, M. W M, Lee, W. M, Cheng, C Y.
(2009). 14-3-3 and its binding partners are regulators of protein-protein interactions during spermatogenesis. J Endocrinol
202: 327-336
[Abstract] [Full Text] -
Maures, T. J., Chen, L., Carter-Su, C.
(2009). Nucleocytoplasmic Shuttling of the Adapter Protein SH2B1{beta} (SH2-B{beta}) Is Required for Nerve Growth Factor (NGF)-Dependent Neurite Outgrowth and Enhancement of Expression of a Subset of NGF-Responsive Genes. Mol. Endocrinol.
23: 1077-1091
[Abstract] [Full Text] -
Urbich, C., Rossig, L., Kaluza, D., Potente, M., Boeckel, J.-N., Knau, A., Diehl, F., Geng, J.-G., Hofmann, W.-K., Zeiher, A. M., Dimmeler, S.
(2009). HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. Blood
113: 5669-5679
[Abstract] [Full Text] -
Liu, Y., Contreras, M., Shen, T., Randall, W. R., Schneider, M. F.
(2009). {alpha}-Adrenergic signalling activates protein kinase D and causes nuclear efflux of the transcriptional repressor HDAC5 in cultured adult mouse soleus skeletal muscle fibres. J. Physiol.
587: 1101-1115
[Abstract] [Full Text] -
Backs, J., Backs, T., Bezprozvannaya, S., McKinsey, T. A., Olson, E. N.
(2008). Histone Deacetylase 5 Acquires Calcium/Calmodulin-Dependent Kinase II Responsiveness by Oligomerization with Histone Deacetylase 4. Mol. Cell. Biol.
28: 3437-3445
[Abstract] [Full Text] -
Paroni, G., Cernotta, N., Dello Russo, C., Gallinari, P., Pallaoro, M., Foti, C., Talamo, F., Orsatti, L., Steinkuhler, C., Brancolini, C.
(2008). PP2A Regulates HDAC4 Nuclear Import. Mol. Biol. Cell
19: 655-667
[Abstract] [Full Text] -
Illi, B., Russo, C. D., Colussi, C., Rosati, J., Pallaoro, M., Spallotta, F., Rotili, D., Valente, S., Ragone, G., Martelli, F., Biglioli, P., Steinkuhler, C., Gallinari, P., Mai, A., Capogrossi, M. C., Gaetano, C.
(2008). Nitric Oxide Modulates Chromatin Folding in Human Endothelial Cells via Protein Phosphatase 2A Activation and Class II Histone Deacetylases Nuclear Shuttling. Circ. Res.
102: 51-58
[Abstract] [Full Text] -
Paroni, G., Fontanini, A., Cernotta, N., Foti, C., Gupta, M. P., Yang, X.-J., Fasino, D., Brancolini, C.
(2007). Dephosphorylation and Caspase Processing Generate Distinct Nuclear Pools of Histone Deacetylase 4. Mol. Cell. Biol.
27: 6718-6732
[Abstract] [Full Text] -
Lim, S., Luo, M., Koh, M., Yang, M., bin Abdul Kadir, M. N., Tan, J. H., Ye, Z., Wang, W., Melamed, P.
(2007). Distinct Mechanisms Involving Diverse Histone Deacetylases Repress Expression of the Two Gonadotropin {beta}-Subunit Genes in Immature Gonadotropes, and Their Actions Are Overcome by Gonadotropin-Releasing Hormone. Mol. Cell. Biol.
27: 4105-4120
[Abstract] [Full Text] -
Hoshino, H., Nishino, T. G., Tashiro, S., Miyazaki, M., Ohmiya, Y., Igarashi, K., Horinouchi, S., Yoshida, M.
(2007). Co-repressor SMRT and Class II Histone Deacetylases Promote Bach2 Nuclear Retention and Formation of Nuclear Foci that are Responsible for Local Transcriptional Repression. J Biochem
141: 719-727
[Abstract] [Full Text] -
Little, G. H., Bai, Y., Williams, T., Poizat, C.
(2007). Nuclear Calcium/Calmodulin-dependent Protein Kinase II{delta} Preferentially Transmits Signals to Histone Deacetylase 4 in Cardiac Cells. J. Biol. Chem.
282: 7219-7231
[Abstract] [Full Text] -
Haberland, M., Arnold, M. A., McAnally, J., Phan, D., Kim, Y., Olson, E. N.
(2007). Regulation of HDAC9 Gene Expression by MEF2 Establishes a Negative-Feedback Loop in the Transcriptional Circuitry of Muscle Differentiation. Mol. Cell. Biol.
27: 518-525
[Abstract] [Full Text] -
Portal, D., Rosendorff, A., Kieff, E.
(2006). Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc. Natl. Acad. Sci. USA
103: 19278-19283
[Abstract] [Full Text] -
Tang, H., Goldman, D.
(2006). Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade. Proc. Natl. Acad. Sci. USA
103: 16977-16982
[Abstract] [Full Text] -
Sucharov, C. C., Langer, S., Bristow, M., Leinwand, L.
(2006). Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A. Am. J. Physiol. Cell Physiol.
291: C1029-C1037
[Abstract] [Full Text] -
Dequiedt, F., Martin, M., Von Blume, J., Vertommen, D., Lecomte, E., Mari, N., Heinen, M.-F., Bachmann, M., Twizere, J.-C., Huang, M. C., Rider, M. H., Piwnica-Worms, H., Seufferlein, T., Kettmann, R.
(2006). New Role for hPar-1 Kinases EMK and C-TAK1 in Regulating Localization and Activity of Class IIa Histone Deacetylases.. Mol. Cell. Biol.
26: 7086-7102
[Abstract] [Full Text] -
Xu, J., Gong, N. L., Bodi, I., Aronow, B. J., Backx, P. H., Molkentin, J. D.
(2006). Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice. J. Biol. Chem.
281: 9152-9162
[Abstract] [Full Text] -
Matthews, S. A., Liu, P., Spitaler, M., Olson, E. N., McKinsey, T. A., Cantrell, D. A., Scharenberg, A. M.
(2006). Essential Role for Protein Kinase D Family Kinases in the Regulation of Class II Histone Deacetylases in B Lymphocytes. Mol. Cell. Biol.
26: 1569-1577
[Abstract] [Full Text] -
Liu, F., Pore, N., Kim, M., Voong, K. R., Dowling, M., Maity, A., Kao, G. D.
(2006). Regulation of Histone Deacetylase 4 Expression by the SP Family of Transcription Factors. Mol. Biol. Cell
17: 585-597
[Abstract] [Full Text] -
Basile, V., Mantovani, R., Imbriano, C.
(2006). DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines. J. Biol. Chem.
281: 2347-2357
[Abstract] [Full Text] -
Backs, J., Olson, E. N.
(2006). Control of Cardiac Growth by Histone Acetylation/Deacetylation. Circ. Res.
98: 15-24
[Abstract] [Full Text] -
Spiegelberg, B. D., Hamm, H. E.
(2005). G{beta}{gamma} Binds Histone Deacetylase 5 (HDAC5) and Inhibits Its Transcriptional Co-repression Activity. J. Biol. Chem.
280: 41769-41776
[Abstract] [Full Text] -
Baranek, C., Sock, E., Wegner, M.
(2005). The POU protein Oct-6 is a nucleocytoplasmic shuttling protein. Nucleic Acids Res
33: 6277-6286
[Abstract] [Full Text] -
Bolger, T. A., Yao, T.-P.
(2005). Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death. J. Neurosci.
25: 9544-9553
[Abstract] [Full Text] -
Bridges, D., Moorhead, G. B. G.
(2005). 14-3-3 Proteins: A Number of Functions for a Numbered Protein. Sci Signal
2005: re10-re10
[Abstract] [Full Text] -
Jarecki, J., Chen, X., Bernardino, A., Coovert, D. D., Whitney, M., Burghes, A., Stack, J., Pollok, B. A.
(2005). Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum Mol Genet
14: 2003-2018
[Abstract] [Full Text] -
Lynch, J., Guo, L., Gelebart, P., Chilibeck, K., Xu, J., Molkentin, J. D., Agellon, L. B., Michalak, M.
(2005). Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca2+-dependent signaling cascade. JCB
170: 37-47
[Abstract] [Full Text] -
Chang, S., Bezprozvannaya, S., Li, S., Olson, E. N.
(2005). An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc. Natl. Acad. Sci. USA
102: 8120-8125
[Abstract] [Full Text] -
Yang, X.-J., Gregoire, S.
(2005). Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication. Mol. Cell. Biol.
25: 2873-2884
[Full Text] -
Parra, M., Kasler, H., McKinsey, T. A., Olson, E. N., Verdin, E.
(2005). Protein Kinase D1 Phosphorylates HDAC7 and Induces Its Nuclear Export after T-cell Receptor Activation. J. Biol. Chem.
280: 13762-13770
[Abstract] [Full Text] -
Liu, Y., Randall, W. R., Schneider, M. F.
(2005). Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. JCB
168: 887-897
[Abstract] [Full Text] -
Deng, X., Ewton, D. Z., Mercer, S. E., Friedman, E.
(2005). Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation. J. Biol. Chem.
280: 4894-4905
[Abstract] [Full Text] -
Jonas, B. A., Privalsky, M. L.
(2004). SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling Pathways. J. Biol. Chem.
279: 54676-54686
[Abstract] [Full Text] -
Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., McKinsey, T. A.
(2004). Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Mol. Cell. Biol.
24: 8374-8385
[Abstract] [Full Text] -
Kato, H., Tamamizu-Kato, S., Shibasaki, F.
(2004). Histone Deacetylase 7 Associates with Hypoxia-inducible Factor 1{alpha} and Increases Transcriptional Activity. J. Biol. Chem.
279: 41966-41974
[Abstract] [Full Text] -
Li, X., Song, S., Liu, Y., Ko, S.-H., Kao, H.-Y.
(2004). Phosphorylation of the Histone Deacetylase 7 Modulates Its Stability and Association with 14-3-3 Proteins. J. Biol. Chem.
279: 34201-34208
[Abstract] [Full Text] -
Jensik, P. J., Huggenvik, J. I., Collard, M. W.
(2004). Identification of a Nuclear Export Signal and Protein Interaction Domains in Deformed Epidermal Autoregulatory Factor-1 (DEAF-1). J. Biol. Chem.
279: 32692-32699
[Abstract] [Full Text] -
Bridges, D., Moorhead, G. B. G.
(2004). 14-3-3 Proteins: A Number of Functions for a Numbered Protein. Sci Signal
2004: re10-re10
[Abstract] [Full Text] -
Merla, G., Howald, C., Antonarakis, S. E., Reymond, A.
(2004). The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3. Hum Mol Genet
13: 1505-1514
[Abstract] [Full Text] -
la Cour, T., Kiemer, L., Molgaard, A., Gupta, R., Skriver, K., Brunak, S.
(2004). Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel
17: 527-536
[Abstract] [Full Text] -
Paroni, G., Mizzau, M., Henderson, C., Del Sal, G., Schneider, C., Brancolini, C.
(2004). Caspase-dependent Regulation of Histone Deacetylase 4 Nuclear-Cytoplasmic Shuttling Promotes Apoptosis. Mol. Biol. Cell
15: 2804-2818
[Abstract] [Full Text] -
McGee, S. L., Hargreaves, M.
(2004). Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes
53: 1208-1214
[Abstract] [Full Text] -
Tanaka, K., Shouguchi-Miyata, J., Miyamoto, N., Ikeda, J.-E
(2004). Novel Nuclear Shuttle Proteins, HDBP1 and HDBP2, Bind to Neuronal Cell-specific cis-Regulatory Element in the Promoter for the Human Huntington's Disease Gene. J. Biol. Chem.
279: 7275-7286
[Abstract] [Full Text] -
Polly, P., Haddadi, L. M., Issa, L. L., Subramaniam, N., Palmer, S. J., Tay, E. S. E., Hardeman, E. C.
(2003). hMusTRD1{alpha}1 Represses MEF2 Activation of the Troponin I Slow Enhancer. J. Biol. Chem.
278: 36603-36610
[Abstract] [Full Text] -
Akazawa, H., Komuro, I.
(2003). Roles of Cardiac Transcription Factors in Cardiac Hypertrophy. Circ. Res.
92: 1079-1088
[Abstract] [Full Text] -
Berger, I., Bieniossek, C., Schaffitzel, C., Hassler, M., Santelli, E., Richmond, T. J.
(2003). Direct Interaction of Ca2+/Calmodulin Inhibits Histone Deacetylase 5 Repressor Core Binding to Myocyte Enhancer Factor 2. J. Biol. Chem.
278: 17625-17635
[Abstract] [Full Text] -
Czubryt, M. P., McAnally, J., Fishman, G. I., Olson, E. N.
(2003). Regulation of peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha ) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA
100: 1711-1716
[Abstract] [Full Text] -
Eilers, A. L., Sundwall, E., Lin, M., Sullivan, A. A., Ayer, D. E.
(2002). A Novel Heterodimerization Domain, CRM1, and 14-3-3 Control Subcellular Localization of the MondoA-Mlx Heterocomplex. Mol. Cell. Biol.
22: 8514-8526
[Abstract] [Full Text] -
Takemori, H., Katoh, Y., Horike, N., Doi, J., Okamoto, M.
(2002). ACTH-induced Nucleocytoplasmic Translocation of Salt-inducible Kinase. IMPLICATION IN THE PROTEIN KINASE A-ACTIVATED GENE TRANSCRIPTION IN MOUSE ADRENOCORTICAL TUMOR CELLS. J. Biol. Chem.
277: 42334-42343
[Abstract] [Full Text] -
Zhang, C. L., McKinsey, T. A., Olson, E. N.
(2002). Association of Class II Histone Deacetylases with Heterochromatin Protein 1: Potential Role for Histone Methylation in Control of Muscle Differentiation. Mol. Cell. Biol.
22: 7302-7312
[Abstract] [Full Text] -
Rehberg, S., Lischka, P., Glaser, G., Stamminger, T., Wegner, M., Rosorius, O.
(2002). Sox10 Is an Active Nucleocytoplasmic Shuttle Protein, and Shuttling Is Crucial for Sox10-Mediated Transactivation. Mol. Cell. Biol.
22: 5826-5834
[Abstract] [Full Text] -
Lazaro, J.-B., Bailey, P. J., Lassar, A. B.
(2002). Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev.
16: 1792-1805
[Abstract] [Full Text] -
Galasinski, S. C., Resing, K. A., Goodrich, J. A., Ahn, N. G.
(2002). Phosphatase Inhibition Leads to Histone Deacetylases 1 and 2 Phosphorylation and Disruption of Corepressor Interactions. J. Biol. Chem.
277: 19618-19626
[Abstract] [Full Text] -
Huang, Y., Tan, M., Gosink, M., Wang, K. K. W., Sun, Y.
(2002). Histone Deacetylase 5 Is Not a p53 Target Gene, But Its Overexpression Inhibits Tumor Cell Growth and Induces Apoptosis. Cancer Res.
62: 2913-2922
[Abstract] [Full Text] -
Kao, H.-Y., Verdel, A., Tsai, C.-C., Simon, C., Juguilon, H., Khochbin, S.
(2001). Mechanism for Nucleocytoplasmic Shuttling of Histone Deacetylase 7. J. Biol. Chem.
276: 47496-47507
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»